Heterogeneity is a major challenge in cancer treatment, which has a profound impact on cancer evolution & metastasis and drug resistance. With the developments of new technologies, there emerge successive achievements with great significance on clinical therapeutics. This symposium will focus on cancer heterogeneity, promoting the clinical translation of research.

This symposium is one of the top-ranked meetings in the field of cancer evolution and heterogeneity in China. Through participating in it, you can learn more about the processing of technologies, the whole industry and the market of tumor heterogeneity in China. Welcome to this academic banquet! Bioon will try our best to provide an excellent platform for you to communicate with China's first-class experts and senior managers, as well as to expand your business in China!